secwatch.observer — SEC 8-K summary
======================================

Issuer:     ELITE PHARMACEUTICALS INC /NV/ (ELTP)
CIK:        0001053369
Form:       8-K
Filed at:   2025-08-08T23:59:59+00:00
Accession:  0001493152-25-011765
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Elite Pharmaceuticals announces Q1 FY2026 results release on Aug 14, conference call Aug 15
--------------------------------------------------------------------------------

- Financial results for Q1 FY2026 (ended June 30, 2025) to be released August 14, 2025.
- Conference call to discuss results and provide corporate update on August 15, 2025 at 11:30 AM EDT.
- Dial-in: 1-800-346-7359 (domestic) or 1-973-528-0008 (intl), conference ID 98840.
- Stockholders can submit questions by email to dianne@elitepharma.com by deadlines: general by Aug 13, financial by Aug 14.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1053369/000149315225011765/0001493152-25-011765-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1053369/000149315225011765/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-011765

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer